Thailand COVID-19

While it is unlikely to unseat Prayut Chan-o-cha, the debate will allow the opposition to exact a political cost from the government for its handling of the pandemic.

The current COVID-19 outbreak has exacerbated the country's already wide gap between rich and poor.

In recent weeks, the region has seen more than twice as many deaths from the coronavirus than North America.

With COVID-19 spiraling out of control in Thailand, the $683 million purchase has again drawn criticism.

The country's slow vaccine rollout has heaped pressure on Prime Minister Prayut Chan-o-cha's government.

Simmering anti-government sentiment has been compounded by Prayut's failures to contain the COVID-19 pandemic.

Will mounting evidence about the limited efficacy of Chinese-made vaccines spell the end for Beijing's vaccine diplomacy?

At least half of the region's 11 nations have seen record daily infection counts over the past week.

The government hopes that the “Phuket sandbox” scheme will lead to the revival of Thailand's tourist industry.

Until Southeast Asian nations achieve widespread vaccination distribution, they will continue to struggle with periodic outbreaks and lockdowns.

Thailand's ambitious plans for economic reopening are being undermined by the country's sluggish COVID-19 vaccine campaign.

The country's health authorities are relying heavily on the local production of AstraZeneca vaccines.